TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

A Little More Research, page-5

  1. thymus
    1,975 Posts.
    lightbulb Created with Sketch. 100
    clock Created with Sketch.
    25/03/15
    22:09
    Post #: 14981278
    Thanks Rev and Puzzled for the research.

    I still think I think the crux of the matter is that the EMA has not previously dealt with a 'device' that also has pharmaceutical action.The fact that they have been forced by legal means to accept the device classification does not help either.
    TIS Price at posting: 18.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Strong copper-gold surface results confirmed at Fortuna Project, revealing significant mineralisation potential
right-arrow Created with Sketch.
NEWS Significant copper and TREO results from West Arunta Project indicate a substantial multi-million tonne copper resource, with mineralisation starting from surface
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.